Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Safety and Efficacy of Anti-BCMA/GPRC5D CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma(rr/MM)
ClinicalTrials.gov study NCT05509530. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Role of the Host Microbiota and Il-17 in Favoring Multiple Myeloma Progression
ClinicalTrials.gov study NCT05712967. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
A Study of ION251 Administered to Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04398485. IPD Sharing: NO. Countries: 1. Publications: 1.
A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Received Three or More Lines of Therapy
ClinicalTrials.gov study NCT05998928. IPD Sharing: NO. Countries: 1. Publications: 2.
Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients
ClinicalTrials.gov study NCT03194867. IPD Sharing: YES. Countries: 10. Publications: 0.
Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients
ClinicalTrials.gov study NCT04802356. IPD Sharing: NO. Countries: 1. Publications: 10.
Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma
ClinicalTrials.gov study NCT00775502. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Studies in Patients With Multiple Myeloma and Renal Failure Due to Myeloma Cast Nephropathy
ClinicalTrials.gov study NCT01208818. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
ClinicalTrials.gov study NCT00900263. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00499577. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00415064. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Human BCMA Targeted T Cells Injection Therapy for BCMA-positive Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04003168. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients
ClinicalTrials.gov study NCT05218603. IPD Sharing: NO. Countries: 1. Publications: 34.
Study of bb21217 in Multiple Myeloma
ClinicalTrials.gov study NCT03274219. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I/II Study of hLL1 in Multiple Myeloma
ClinicalTrials.gov study NCT00421525. IPD Sharing: Not stated. Countries: 1. Publications: 6.
A Study of Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)
ClinicalTrials.gov study NCT00091624. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Velcade, Thalidomide, Dexamethasone and Panobinostat Treatment and Panobinostat Maintenance in Multiple Myeloma
ClinicalTrials.gov study NCT02145715. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Wild-Type Reovirus, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02514382. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma
ClinicalTrials.gov study NCT02237261. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01593410. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.